Organogenesis Holdings Inc.
ORGO
$2.61
$0.030.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 49.56% | 49.32% | |||
| Total Other Revenue | 42.18% | 66.81% | |||
| Total Revenue | 49.54% | 49.36% | |||
| Cost of Revenue | 37.70% | 31.20% | |||
| Gross Profit | 53.29% | 56.20% | |||
| SG&A Expenses | 26.44% | 7.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.61% | 15.08% | |||
| Operating Income | 194.29% | 304.66% | |||
| Income Before Tax | 199.75% | 278.81% | |||
| Income Tax Expenses | 4,946.93% | 83.33% | |||
| Earnings from Continuing Operations | 102.62% | 329.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 102.62% | 329.63% | |||
| EBIT | 194.29% | 304.66% | |||
| EBITDA | 159.26% | 532.23% | |||
| EPS Basic | 141.66% | 280.88% | |||
| Normalized Basic EPS | 189.22% | 323.94% | |||
| EPS Diluted | 124.09% | 271.88% | |||
| Normalized Diluted EPS | 168.58% | 317.10% | |||
| Average Basic Shares Outstanding | 0.03% | 0.02% | |||
| Average Diluted Shares Outstanding | 7.72% | 3.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||